VXc-486, a Gyrase B Inhibitor, Has Potential to Treat Tuberculosis
Tuberculosis (TB) is an important infectious disease threat worldwide. HIV coinfection/immunosuppression and widespread drug resistance contributes to the challenge of controlling TB. TB resulted from Mycobacterium tuberculosis. It is a…